Pharmacogenomics social, ethical, and clinical dimensions
| Otros Autores: | |
|---|---|
| Formato: | Libro |
| Idioma: | Inglés |
| Publicado: |
New York :
Wiley-Liss
cop. 2003.
|
| Materias: | |
| Ver en Universidad de Navarra: | https://unika.unav.edu/discovery/fulldisplay?docid=alma991004859729708016&context=L&vid=34UNAV_INST:VU1&search_scope=34UNAV_TODO&tab=34UNAV_TODO&lang=es |
Tabla de Contenidos:
- Public attitudes about pharmacogenomics / Mark A. Rothstein and Carlton A. Hornung
- Pharmacogenomics: genes and genetic variation meet pharmacology and toxicology / Harvey W. Mohrenweiser
- The implications of population genetics for pharmacogenomics / Craig L. Hanis
- Genome research and minorities / Henry T. Greely
- Drug development strategies / Penelope K. Manasco
- FDA regulation of pharmacogenomics / David W. Feigal
- Intellectual property and commercial aspects of pharmacogenomics / Gary Cohen, Scott Brown and Allen Nunnally
- Integration of pharmacogenomics into medical practice / Gilbert S. Omenn and Arno G. Motulsky
- Clinical utility of pharmacogenetics and pharmacogenomics / Neil A. Holtzman
- Medical liability for pharmacogenomics
- Larry I. Palmer
- Pharmacogenomics and pharmacy practice / David B. Brushwood
- Economic implications of pharmacogenomics / C.E. Reeder and W. Michael Dickson
- Pharmacogenomics and the social construction of identity / Morris W. Fostern
- Pharmacogenomics: considerations for communities of color / Laurie Nsiah-Jefferson
- Constitutional issues in the use of pharmacogenomic variations associated with race / John A. Robertson.
